Nowadays, ICIs, such as programmed cell death-1(PD-1), programmed cell death-Ligand 1 (PD-L1), and cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), represent the most promising cancer treatment. This evidence concerns the gene CTLA4 and cancer.